In a fluorescein isothiocyanate (FITC)-induced AD mouse model, formononetin was observed to improve E-cadherin localization, suppress the expression of TSLP and IL-33, reinforce the epidermal barrier integrity, and attenuate immune activation (Li et al., 2018). The gene discussed is IL33; the disease is Alzheimer disease.